HCP
TXG icon

Hexagon Capital Partners’s 10x Genomics TXG Stock Holding History

Hexagon Capital Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115
Closed -$1K – 1599
2025
Q1 		$1K Buy
115
+71
+161% +$895 ﹤0.01% 1552
2024
Q4 		$632 Sell
44
-35
-44% -$552 ﹤0.01% 1660
2024
Q3 		$1.78K Sell
79
-27
-25% -$558 ﹤0.01% 1243
2024
Q2 		$2.06K Buy
+106
New +$2.78K ﹤0.01% 1168

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hexagon Capital Partners's TXG Position: Q2 2025 in Review

Hexagon Capital Partners sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 115 shares — an estimated $1K sold.

Hexagon Capital Partners first reported a position in TXG in Q2 2024 and held it in 4 quarters. The position peaked at $2.06K in Q2 2024. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Hexagon Capital Partners reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 115 10x Genomics shares in Q2 2025, an estimated $1K.
  • Hexagon Capital Partners first reported a position in 10x Genomics in Q2 2024 and held it in 4 quarters.
  • Hexagon Capital Partners's 10x Genomics position peaked at $2.06K in Q2 2024.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.